by John A. Jenkins | Oct 25, 2023 | FDA, FOIA, Litigation, Pharmaceuticals
In FOIAengine, a Slew of Requests About Ivermectin Robert Califf headed up the Food and Drug Administration during the last year of the Obama Administration. By the time Califf spun through the revolving door, returning to his old job early in 2022, he’d picked up...
by Randy E. Miller | Sep 20, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Identifies 57 New FOIA Requests to FDA Hedge funds and other financial institutions made 57 Freedom of Information Act (FOIA) requests last month to the Food and Drug Administration (FDA) seeking information about adverse drug events and...
by John A. Jenkins | Aug 16, 2023 | FDA, FOIA, Pharmaceuticals
FOIAengine: A Request Was a Signal, Months Before Bad News Hit Columbia University’s New York State Psychiatric Institute has a storied research history stretching back to its founding in 1895 as one of the first institutions in the U.S. to integrate teaching,...
by Randy E. Miller | Aug 2, 2023 | FDA, FOIA, Law Firms, Litigation, Non-Profits, Pharmaceuticals
FOIAengine Reveals Requests from a Major Litigant During May and June of this year, the conservative watchdog group Judicial Watch led the way among non-profit organizations in filing Freedom of Information Act (FOIA) requests to the Food and Drug Administration...
